HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+7.32%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(-3.7%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-5.88%
Top 10 Holdings %
Top 10 Hldgs %
56.48%
Holding
62
New
19
Increased
12
Reduced
10
Closed
20
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$105M |
| 2 |
Zimmer Biomet
ZBH
|
$92.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$65M |
| 4 |
DexCom
DXCM
|
$59.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$53.4M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$129M |
| 2 |
Edwards Lifesciences
EW
|
$115M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$108M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$82.1M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$74.4M |
Sector Composition
| 1 | Healthcare | 71.96% |
| 2 | Financials | 0% |
| 3 | Industrials | 0% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
51
DELISTED
Allergan plc
AGN
| – | – |
-475,000
| Closed | -$129M |
|
|
CYAD
52
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| – | – |
-87,181
| Closed | -$3.65M |
|
|
RAD
53
DELISTED
Rite Aid Corporation
RAD
| – | – |
-13,525,000
| Closed | -$82.1M |
|
54
Welltower
WELL
$112B
| – | – |
-72,750
| Closed | -$4.93M |
|
55
Ventas
VTR
$30.7B
| – | – |
-87,020
| Closed | -$4.88M |
|
56
United Therapeutics
UTHR
$17.7B
| – | – |
-170,400
| Closed | -$22.4M |
|
57
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-150,000
| Closed | -$5.97M |
|
58
McKesson
MCK
$85.9B
| – | – |
-275,000
| Closed | -$50.9M |
|
59
Catalyst Pharmaceutical
CPRX
$2.42B
| – | – |
-385,500
| Closed | -$1.16M |
|
60
Assembly Biosciences
ASMB
$183M
| – | – |
-318,621
| Closed | -$3.05M |
|
61
Agilent Technologies
A
$35.5B
| – | – |
-325,500
| Closed | -$11.2M |
|
|
SRCL
62
DELISTED
Stericycle Inc
SRCL
| – | – |
-775,000
| Closed | -$108M |
|